# VersaBank: financial statements, quarterly

VBNK · Nasdaq · CIK 1690639 · [Financials](/sectors/financials.md) · fiscal year ends Oct 31

Pages: [Overview](/companies/vbnk.md) · [Financials](/companies/vbnk/financials.md) · [Filings](/companies/vbnk/filings.md) · [Insiders](/companies/vbnk/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/vbnk/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2019-10-31) | period not labelled (2020-10-31) | FY2021 (2021-10-31) | FY2022 (2022-10-31) | FY2023 (2023-10-31) | FY2024 (2024-10-31) | FY2025 (2025-10-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [139](/filings/0001437749-22-001814.md) | [258](/filings/0001437749-22-028604.md) | [272](/filings/0001437749-23-034288.md) | [88.6](/filings/0001437749-24-036917.md) | [132](/filings/0001437749-25-037310.md) | [225](/filings/0001437749-25-037310.md) | [582](/filings/0001437749-25-037310.md) |
| Total assets | $m | not reported | [1,944](/filings/0001437749-22-001814.md) | [2,415](/filings/0001437749-22-028604.md) | [3,266](/filings/0001437749-23-034288.md) | [4,202](/filings/0001437749-24-036917.md) | [4,838](/filings/0001437749-25-037310.md) | [5,808](/filings/0001437749-25-037310.md) |
| Total liabilities | $m | not reported | [1,689](/filings/0001437749-22-001814.md) | [2,083](/filings/0001437749-22-028604.md) | [2,915](/filings/0001437749-23-034288.md) | [3,824](/filings/0001437749-24-036917.md) | [4,439](/filings/0001437749-25-037310.md) | [5,276](/filings/0001437749-25-037310.md) |
| Shareholders' equity | $m | not reported | [255](/filings/0001437749-22-001814.md) | [332](/filings/0001437749-22-028604.md) | [351](/filings/0001437749-23-034288.md) | [377](/filings/0001437749-24-036917.md) | [399](/filings/0001437749-25-037310.md) | [533](/filings/0001437749-25-037310.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Total assets: ifrs-full:Assets
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity

Shares outstanding: 26,002,577 at 2024-10-31, from the cover of the [40-F/A filed 2025-04-15](/filings/0001437749-25-012028.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.